After gaining a fundamental supporter, here's how aggressive traders could play the stock.
Let's see what the the charts and indicators look like.
Share prices peaked in December.
BSX has rallied the past nine months.
The trading days between the gaps look like an island surrounded by water.
Let's drill down on the charts.
These recession-resilient names offer above-average dividend yields and decent growth prospects.
The tech giant's stock won a buy rating from Goldman Sachs, and its work on a medical innovation could be a game-changer.
Here's a way to trade Vir Biotechnology.
Let's see if the charts and indicators are playing our song.